# Droxidopa

NDC: 59651-377
Generic name: Droxidopa
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20210218

FDA application: ANDA214387

## Active ingredients

- DROXIDOPA: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-377"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-377
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff263c9a-3db2-45ac-9ba6-8fca47199604